Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin H Eng

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 11, 2012
Postoperative visual acuity in patients with fuchs dystrophy undergoing descemet membrane-stripping automated endothelial keratoplasty: correlation with the severity of histologic changesDorrie M Happ, David A Lewis, Kevin H Eng, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2022
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patientsAnm Nazmul H Khan, Tiffany R Emmons, William J Magner, et al.
Gynecologic Oncology|June 19, 2017
Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort studyJ Brian Szender, Tiffany Emmons, Sarah Belliotti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 12, 2015
Use of common analgesics is not associated with ovarian cancer survivalAlbina N Minlikeeva, Jo L Freudenheim, Wei-Hsuan Lo-Ciganic, et al.
Oncotarget|July 18, 2020
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancerTakemasa Tsuji, Kevin H Eng, Junko Matsuzaki, et al.
Cancer Immunology Research|April 3, 2020
Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding BasophilsAnm Nazmul H Khan, Tiffany R Emmons, Jerry T Wong, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancerAnmbreen Jamroze, Renyuan Zhang, Kriti Ahuja, et al.
International Journal of Cancer|July 3, 2019
Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genesQianqian Zhu, Jianmin Zhang, Yanmin Chen, et al.
Plos Genetics|February 16, 2018
Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry studyKevin H Eng, J Brian Szender, John Lewis Etter, et al.
Leukemia|February 27, 2020
Inhibition of LSD1 in MDS progenitors restores differentiation of CD141<sup>Hi</sup> conventional dendritic cellsPragya Srivastava, Stephanie L Tzetzo, Eduardo Cortes Gomez, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 11, 2012
Postoperative visual acuity in patients with fuchs dystrophy undergoing descemet membrane-stripping automated endothelial keratoplasty: correlation with the severity of histologic changesDorrie M Happ, David A Lewis, Kevin H Eng, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2022
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patientsAnm Nazmul H Khan, Tiffany R Emmons, William J Magner, et al.
Gynecologic Oncology|June 19, 2017
Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort studyJ Brian Szender, Tiffany Emmons, Sarah Belliotti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 12, 2015
Use of common analgesics is not associated with ovarian cancer survivalAlbina N Minlikeeva, Jo L Freudenheim, Wei-Hsuan Lo-Ciganic, et al.
Oncotarget|July 18, 2020
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancerTakemasa Tsuji, Kevin H Eng, Junko Matsuzaki, et al.
Cancer Immunology Research|April 3, 2020
Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding BasophilsAnm Nazmul H Khan, Tiffany R Emmons, Jerry T Wong, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancerAnmbreen Jamroze, Renyuan Zhang, Kriti Ahuja, et al.
International Journal of Cancer|July 3, 2019
Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genesQianqian Zhu, Jianmin Zhang, Yanmin Chen, et al.
Plos Genetics|February 16, 2018
Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry studyKevin H Eng, J Brian Szender, John Lewis Etter, et al.
Leukemia|February 27, 2020
Inhibition of LSD1 in MDS progenitors restores differentiation of CD141<sup>Hi</sup> conventional dendritic cellsPragya Srivastava, Stephanie L Tzetzo, Eduardo Cortes Gomez, et al.
Pageof 8